Bellus Health Stock News

BELLUS Health Inc. (BLU) Latest Stock News & Headlines

BELLUS 59 People Used

News Press Releases Research Reports Zacks Bellus Health (BLU) Reports Q4 Loss, Lags Revenue Estimates Bellus (BLU) delivered earnings and revenue surprises of 35.71% and …

Preview /  Show details

BELLUS Health Stock Forecast, Price & News (TSE:BLU)

BELLUS 56 People Used

BELLUS Health Stock Forecast, Price & News C$7.76 -0.41 (-5.02%) (As of 03/11/2022 04:00 PM ET) Today's Range C$7.70 C$8.18 50-Day Range C$6.96 C$10.17 52-Week Range C$3.32 C$12.59 Volume 59,249 shs Average Volume 121,626 shs Market Capitalization C$825.69 million P/E Ratio N/A Dividend Yield N/A Beta N/A Profile Analyst …

Rating: 3.4/5

Preview /  Show details

BELLUS Health Inc. (BLU.TO) Latest Stock News & Headlines

BELLUS 62 People Used

Get the latest BELLUS Health Inc. (BLU.TO) stock news and headlines to help you in your trading and investment decisions.

Preview /  Show details

BELLUS Health Inc. (BLU) Stock Price, News, Quote

BELLUS 50 People Used

Bellus Health (BLU) Reports Q4 Loss, Lags Revenue Estimates Bellus (BLU) delivered earnings and revenue surprises of 35.71% and 60%, respectively, …

Preview /  Show details

BELLUS Health Inc. (BLU) Stock Price, Quote & News …

BELLUS 59 People Used

What's Going On With BELLUS Health's Stock Today? BELLUS Health Inc (NASDAQ: BLU) is trading higher Monday after the company announced interim analysis from the Phase 2b SOOTHE trial of BLU-5937 in refractory chronic cough. The stock is experiencing hi 5 months ago - Benzinga BELLUS Health Stock Shines After Refractory Chronic Cough Trial …

Preview /  Show details

BELLUS Health Inc. (BLU) Stock Price, News & Info The

BELLUS 59 People Used

A phase 2 trial with the company's chronic-cough candidate hit its primary endpoint. Why Bellus Health Stock Tanked 69.2% Today Todd Campbell Jul 6, 2020 The company's lead drug …

Preview /  Show details

BELLUS HEALTH INC : Stock Market News And Information

BELLUS 54 People Used

Analyst Reco. BELLUS HEALTH : to Participate in the Cowen & Co. 42nd Annual Health Care Conference - For.. HC Wainwright Adjusts BELLUS Health's Price Target to $16 From $14, Reiterates Buy Rati.. BELLUS HEALTH BRIEF : Ended year with US$248.8 million in cash, cash equivalents and short..

Preview /  Show details

BLU Bellus Health Inc — Stock Price And Discussion

BLU 53 People Used

BLU Bellus Health Inc — Stock Price and Discussion Stocktwits. Bellus Health Inc NASDAQ Updated Mar 11, 2022 10:23 PM. BLU 6.07 0.30 (4.71%) Post-Market 0.04 (0.66%) 7,208. Key Data. 52wk Low 2.60. 52wk High 9.84.

Preview /  Show details

BELLUS HEALTH INC : Stock Price CA07987C1059

BELLUS 46 People Used

BELLUS Health Inc. is a clinical stage pharmaceutical company that is focused on developing a P2X3 antagonist to address various afferent hypersensitization-related disorders. The Company’s lead candidate, BLU-5937, is being studied in Phase II clinical trials in refractory chronic cough and chronic pruritus associated with atopic dermatitis. It is developing BLU …

Preview /  Show details

BLU BELLUS Health Inc. Stock Price & News WSJ

BLU 51 People Used

News BELLUS Health Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-0.90 Market Cap $664.60 …

Preview /  Show details

BELLUS Health Inc. (BLU.TO) Stock Price, News, Quote

BELLUS 53 People Used

Bellus Health (BLU) Reports Q4 Loss, Lags Revenue Estimates Bellus (BLU) delivered earnings and revenue surprises of 35.71% and 60%, respectively, …

Preview /  Show details

BELLUS Health (TSX:BLU) Share Price, News & Analysis

BELLUS 58 People Used

BLU Stock Overview BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. About the company Rewards Revenue is forecast to grow 75.62% per year Risk Analysis Makes less than USD$1m in revenue ($16K)

Preview /  Show details

Bellus Health (BLU) Stock News & Signals The Analyst

Bellus 57 People Used

BELLUS Health Inc NASDAQ:BLU stock news. View real-time stock prices and stock quotes. The Technical Analyst. Select Language : BELLUS Health Inc [BLU] Exchange: Nasdaq Global Select Sector: Healthcare Industry: Biotechnology Stock Price, Forecast, Insider, Ratings, Fundamentals & Signals. 3.64% $6.26

Preview /  Show details

BLU: BELLUS Health Inc Stock Price Quote Bloomberg.com

BELLUS 55 People Used

Stock analysis for BELLUS Health Inc (BLU:Toronto) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Preview /  Show details

Related Topics

Frequently Asked Questions

What are analystsforecasts for bellus healths stock?

Their forecasts range from C$14.00 to C$18.00. On average, they anticipate BELLUS Health's share price to reach C$15.25 in the next twelve months. This suggests a possible upside of 90.6% from the stock's current price. View analysts' price targets for BELLUS Health or view top-rated stocks among Wall Street analysts.

What is the upside for bellus healths share price?

Their forecasts range from C$14.00 to C$18.00. On average, they anticipate BELLUS Health's share price to reach C$15.25 in the next twelve months. This suggests a possible upside of 90.6% from the stock's current price.

What did bellus health announce?

LAVAL, Quebec, December 17, 2021--BELLUS Health Inc. (NASDAQ: BLU) (TSX: BLU) (the "Company" or "BELLUS Health") announced today that it has completed its previously-announced underwritten public offering in Canada and the United States (the "Offering") of 25,000,000 common shares at a price to the public of US$8.00 per common share.

Is bellus health blu a biopharma research company?

(See OBSV stock analysis on TipRanks) BELLUS Health (BLU) The second stock we’re looking at, BELLUS Health, is also a clinical stage biopharma research company – but the focus here is on an issue that few of us ever think about.

Popular Searched